Diabetes Board decisions

The Veteran's claims for increased ratings are being remanded due to the receipt of additional VA records. The AOJ will review these records and issue a Supplemental Statement of the Case (SSOC).

The Board has granted service connection for diabetes mellitus, Type II (diabetes), due to herbicide agent exposure and diabetic neuropathy, secondary to service-connected diabetes on a causation basis. The earliest possible effective date is August 10, 2022.

The Veteran's diabetes mellitus, Type II and peripheral neuropathy of the lower extremities have been rated at 20 percent since October 20, 2015. The Board finds that a higher rating is not warranted.,Effective dates for service connection are denied as freestanding claims.

The Board has dismissed the claims for service connection for diabetes mellitus, type II and prostate cancer, both secondary to herbicide exposure. The appeal is dismissed due to the appellant's death.

The Veteran's petition to reopen his claim for service connection for PTSD was granted. The Board also found that the Veteran is entitled to increased ratings for diabetic peripheral neuropathy of the bilateral upper and lower extremities, with a disability rating of 30 percent for each right upper extremity from July 6, 2022, and a disability rating of 40 percent for each left upper extremity from July 6, 2022. The Veteran's lower extremities continue to be rated at 10 percent.

The Veteran's claim for tuberculosis was denied due to lack of new and material evidence.,Service connection for sleep apnea, fatty liver disease (claimed as liver condition), insulin resistance, and diabetes mellitus were all remanded due to insufficient medical opinions regarding their etiology.

The Veteran's TDIU claim was denied for the period prior to August 10, 2022. For the period from August 10, 2022, his combined rating of 100% due to multiple service-connected disabilities rendered him eligible for SMC under a separate TDIU determination.

The Board has remanded the cases for additional development, including obtaining an addendum opinion from a VA examiner to address whether the Veteran's service-connected conditions caused or contributed to his death.

The Veteran's diabetes mellitus type II and bilateral lower extremity peripheral neuropathy have been granted increased ratings, with the right lower extremity receiving a higher rating than left.,TDIU has also been granted from August 25, 2018 to April 12, 2022.

The Board has remanded the case due to insufficient evidence regarding the Veteran's exposure to herbicide agents and the nature and etiology of his diabetes. The Veteran is also seeking service connection for sleep apnea, which may be related to obesity caused by his right knee disability.

The Veteran's claims for service connection and increased ratings were granted, with effective dates of March 13, 2017. The SMC claim was denied.

The Board has reopened the claims for service connection for obesity, OSA, DM, hypertension, and bilateral plantar fasciitis due to new and material evidence. The appeals are granted.

The Board denied the Veteran's claim for service connection for type II diabetes mellitus, finding that there was no evidence of herbicide exposure and insufficient evidence to establish a link between the condition and military service.

The Board has remanded the Veteran's claims for service connection due to insufficient VA opinions addressing his exposure to hazardous chemicals and herbicide agents during service.

The Board has remanded the Veteran's claims for service connection due to insufficient evidence regarding whether his sleep apnea, diabetes mellitus type 2, hypertension, erectile dysfunction, and bilateral foot condition are related to or aggravated by his service-connected posttraumatic stress disorder.

The Veteran's claims for bilateral hearing loss, pseudofolliculitis barbae, and right knee disability were denied in previous rating decisions. The claim for DM II was remanded.,New evidence received since the last denial does not relate to the unestablished facts of these claims.

The Veteran's service-connected disabilities, including diabetes mellitus with erectile dysfunction and associated conditions, became effective on February 3, 2006.

The Board has remanded the Veteran's claims for service connection due to insufficient evidence and inextricably intertwined issues. The claims include lichen planus, type II diabetes, hypertension, and an acquired psychiatric disorder.

The Board has remanded the Veteran's claims of service connection for prostate condition, diabetes mellitus, type II, and kidney cancer due to potential herbicide exposure during service. The AOJ is instructed to obtain VA treatment records, determine if the Veteran was exposed to a TERA (herbicides or other), provide a TERA examination with opinion, and readjudicate the claims.

The Veteran's service-connected diabetes mellitus with erectile dysfunction is granted a 40 percent evaluation for the entire period on appeal, resolving all doubt in his favor.